Form 8-K - Current report:
SEC Accession No. 0001193125-25-174958
Filing Date
2025-08-07
Accepted
2025-08-07 07:35:07
Documents
15
Period of Report
2025-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d14149d8k.htm   iXBRL 8-K 29481
2 EX-99.1 d14149dex991.htm EX-99.1 70375
7 GRAPHIC g14149g0806234234175.jpg GRAPHIC 3007
  Complete submission text file 0001193125-25-174958.txt   265569

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sln-20250807.xsd EX-101.SCH 3535
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sln-20250807_def.xml EX-101.DEF 14078
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sln-20250807_lab.xml EX-101.LAB 22975
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sln-20250807_pre.xml EX-101.PRE 14925
17 EXTRACTED XBRL INSTANCE DOCUMENT d14149d8k_htm.xml XML 5869
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-39487 | Film No.: 251191631
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)